Back to search
FDAFDA · Food and drugs·Recall number D-1354-2014

ParaGard T 380A - Intrauterine Copper Contraceptive, 176 mg of copper wire, Duramed Pharmaceuticals Inc, a subsidiary of Barr Pharmaceuticals, Inc., Pomona, NY

Published June 4, 2014 · Recall initiated: March 21, 2014

Summary

FDA records drug Class II recall D-1354-2014, published June 4, 2014 and initiated March 21, 2014. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 47890; Lot: 508004, exp. 4/2015, NDC 51285-204-01, Single Unit 508004, exp. 4/2015, NDC 51285-204-02, Carton of 5 Units. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-sterility: due to a failed sterility test

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
NY and KY
Lot
508004, exp. 4/2015, NDC 51285-204-01, Single Unit 508004, exp. 4/2015, NDC 51285-204-02, Carton of 5 Units
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ParaGard T 380A - Intrauterine Copper Contraceptive, 176 mg of copper wire, Duramed Pharmaceuticals Inc, a subsidiary of Barr Pharmaceuticals, Inc., Pomona, NY recalled?

Yes. FDA published recall D-1354-2014 on June 4, 2014. Reported hazard: Non-sterility: due to a failed sterility test

What should I do if I have this product?

Voluntary: Firm initiated · Letter